Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dasatinib - Xspray Pharma

Drug Profile

Dasatinib - Xspray Pharma

Alternative Names: Dasynoc; HyNap-Dasa; XS-004

Latest Information Update: 19 Aug 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Xspray Pharma
  • Class Alcohols; Amides; Amines; Antineoplastics; Chlorobenzenes; Ethanolamines; Piperazines; Pyrimidines; Small molecules; Thiadiazoles; Thiazoles
  • Mechanism of Action Bcr-Abl fusion protein modulators; Bcr-Abl tyrosine kinase inhibitors; EphA2 receptor antagonists; Platelet-derived growth factor beta receptor antagonists; Proto-oncogene protein c-kit inhibitors; Src-family kinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Precursor cell lymphoblastic leukaemia-lymphoma; Chronic myeloid leukaemia
  • New Molecular Entity No

Highest Development Phases

  • Preregistration Chronic myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma

Most Recent Events

  • 12 Aug 2025 Dasatinib licensed to Handa Therapeutics
  • 12 Aug 2025 US FDA assigns PDUFA action date of (07/10/2025) for Dasatinib for Chronic myeloid leukemia
  • 19 Sep 2024 Xspray Pharma plans to launch dasatinib in Q1 of 2025 in the US

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top